# BRNS (Barinthus Biotherapeutics PLC) - SEC EDGAR Financial Statements

> Barinthus Biotherapeutics PLC reported $0 in revenue and a net loss of $41.77M for the fiscal year ended December 31, 2025 (down 100.0% year over year).

- Canonical: https://convexityos.com/fundamentals/BRNS
- Markdown: https://convexityos.com/fundamentals/BRNS.md
- SEC CIK: 0001828185
- Reporting currency: USD
- Latest filing period: June 30, 2026
- Last synced: Nov 21, 2026, 05:02 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001828185&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $0 | -100.0% YoY |
| Operating Income | FY 2025 | -$43.73M | Operating profit |
| Net Income | FY 2025 | -$41.77M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$1.02 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$26.43M | Operating CF less CapEx |
| Cash & ST Investments | Jun 30, 2026 | $59.30M | Total debt: $10.29M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $14.97M | $802K | $44.70M | $268K | $4.82M |
| Research & Development | $25.56M | $42.24M | $44.87M | $42.35M | $20.37M | $14.39M |
| Total Operating Expenses | $71.06M | $84.11M | $84.72M | $48.74M | $45.49M | $24.87M |
| **Operating Income** | -$70.56M | -$67.97M | -$83.91M | -$4.04M | -$45.22M | -$20.05M |
| **EBITDA** | -$64.71M | -$62.17M | -$78.48M | $282K | -$44.62M | -$19.84M |
| Interest Income | $1.96M | $2.68M | $2.88M | $3.10M | $2.0K | $0 |
| Interest Expense | $51K | $53K | $28K | $19K | $2.67M | $3.60M |
| Income Before Tax | -$66.63M | -$61.23M | -$76.52M | $850K | -$51.14M | -- |
| Income Tax Expense | -$175K | -$44K | -$3.08M | -$4.47M | -$28K | $95K |
| **Net Income** | -$66.43M | -$61.07M | -$73.35M | $5.34M | -$50.87M | -$17.71M |
| Basic EPS | -$1.64 | -$1.55 | -$1.91 | $0.14 | -$1.96 | -$2.24 |
| **Diluted EPS** | -$1.64 | -$1.55 | -$1.91 | $0.14 | -$1.96 | -$2.24 |
| Basic Shares Outstanding | 40.5M | 39.3M | 38.4M | 37.2M | 25.9M | 7.9M |
| Diluted Shares Outstanding | 40.5M | 39.3M | 38.4M | 38.2M | 25.9M | 7.9M |

### Income Statement (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | $0 | -- | -- | $0 | $14.97M |
| Research & Development | $3.92M | $3.59M | $3.93M | $5.39M | $7.95M | $8.29M | $8.31M | $11.14M |
| Total Operating Expenses | $11.02M | $6.12M | $11.57M | $15.22M | $23.34M | $20.93M | $23.57M | $24.56M |
| **Operating Income** | -$11.02M | -$6.08M | -$11.56M | -$15.07M | -$23.32M | -$20.60M | -$23.39M | -$9.38M |
| **EBITDA** | -$10.20M | -$5.22M | -$10.66M | -$14.16M | -$21.32M | -$18.57M | -$21.96M | -$7.91M |
| Interest Income | $343K | $350K | $406K | $472K | $523K | $556K | $637K | $631K |
| Interest Expense | $14K | $13K | $13K | $13K | $12K | $13K | $12K | $17K |
| Income Before Tax | -$10.62M | -$5.55M | -$11.16M | -$14.64M | -$21.15M | -$19.68M | -$20.59M | -$8.13M |
| Income Tax Expense | -$23K | -$16K | -$57K | -$71K | -$25K | -$22K | $3.0K | -$3.0K |
| **Net Income** | -$10.58M | -$5.53M | -$11.09M | -$14.57M | -$21.12M | -$19.65M | -$20.54M | -$8.11M |
| Basic EPS | -$0.26 | -$0.14 | -- | -$0.36 | -$0.52 | -$0.49 | -- | -$0.21 |
| **Diluted EPS** | -$0.26 | -$0.14 | -- | -$0.36 | -$0.52 | -$0.49 | -- | -$0.21 |
| Basic Shares Outstanding | 40.8M | 40.8M | -- | 40.7M | 40.3M | 40.3M | -- | 39.4M |
| Diluted Shares Outstanding | 40.8M | 40.8M | -- | 40.7M | 40.3M | 40.3M | -- | 39.4M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $70.46M | $110.7M | $142.1M | $194.4M | $214.1M | $43.27M |
| **Cash & Short-Term Investments** | $70.46M | $110.7M | $142.1M | $194.4M | $214.1M | $43.27M |
| Accounts Receivable, Net | -- | -- | -- | $323K | $20K | $518K |
| Other Current Assets | $115K | $344K | $1.47M | $611K | $995K | $29K |
| **Total Current Assets** | $77.79M | $125.7M | $156.9M | $213.0M | $226.8M | $47.90M |
| Property, Plant & Equipment, Net | $3.52M | $7.37M | $11.82M | $7.96M | $1.83M | $629K |
| Goodwill | -- | $0 | $12.21M | $12.21M | $12.63M | -- |
| Intangible Assets | $14.29M | $21.95M | $25.11M | $28.27M | $31.43M | -- |
| **Total Non-Current Assets** | $20.38M | $34.59M | $57.60M | $57.16M | $53.95M | $2.77M |
| **Total Assets** | $98.17M | $160.3M | $214.5M | $270.2M | $280.7M | $50.67M |
| Accounts Payable | $350K | $2.47M | $1.60M | $3.75M | $2.42M | $4.67M |
| Short-Term Debt | -- | -- | -- | -- | $159K | -- |
| Deferred Revenue (Current) | -- | -- | -- | -- | $182K | $245K |
| **Total Current Liabilities** | $10.02M | $15.66M | $12.60M | $12.24M | $11.16M | $7.64M |
| Other Non-Current Liabilities | $1.48M | $1.36M | $1.32M | $965K | -- | -- |
| **Total Non-Current Liabilities** | $13.86M | $14.54M | $14.91M | $14.76M | $17.00M | $46.17M |
| **Total Liabilities** | $23.88M | $30.19M | $27.51M | $27.00M | $28.15M | $53.81M |
| **Total Debt (incl. Leases)** | $11.28M | $12.01M | $12.98M | $8.77M | $7.22M | $1.66M |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $0 |
| Retained Earnings | -$304.1M | -$237.7M | -$176.6M | -$103.2M | -$108.6M | -$57.72M |
| **Total Stockholders' Equity** | $74.21M | $130.0M | $186.8M | $242.9M | $252.1M | -- |
| Total Equity | $74.29M | $130.1M | $187.0M | $243.2M | $252.6M | -$36.91M |

### Balance Sheet (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $59.30M | $65.86M | $70.46M | $74.27M | $86.26M | $99.12M | $110.7M | -- |
| **Cash & Short-Term Investments** | $59.30M | $65.86M | $70.46M | $74.27M | $86.26M | $99.12M | $110.7M | -- |
| Other Current Assets | $151K | $194K | $115K | $663K | $854K | $435K | $344K | $464K |
| **Total Current Assets** | $63.27M | $72.66M | $77.79M | $86.78M | $100.4M | $109.9M | $125.7M | $134.7M |
| Property, Plant & Equipment, Net | $3.04M | $3.27M | $3.52M | $4.52M | $4.51M | $6.20M | $7.37M | $10.72M |
| Goodwill | -- | -- | -- | -- | -- | -- | $0 | $12.21M |
| Intangible Assets | $13.04M | $13.67M | $14.29M | $14.91M | $20.37M | $21.16M | $21.95M | $22.74M |
| **Total Non-Current Assets** | $18.62M | $19.48M | $20.38M | $22.42M | $29.15M | $32.11M | $34.59M | $54.03M |
| **Total Assets** | $81.89M | $92.14M | $98.17M | $109.2M | $129.6M | $142.0M | $160.3M | $188.7M |
| Accounts Payable | $535K | $993K | $350K | $698K | $1.80M | $1.36M | $2.47M | $3.08M |
| **Total Current Liabilities** | $11.42M | $12.00M | $10.02M | $10.80M | $12.72M | $11.98M | $15.66M | $15.07M |
| Other Non-Current Liabilities | $1.49M | $1.47M | $1.48M | $1.46M | $1.47M | $1.40M | $1.36M | $1.41M |
| **Total Non-Current Liabilities** | $13.34M | $13.66M | $13.86M | $13.84M | $14.36M | $14.43M | $14.54M | $14.16M |
| **Total Liabilities** | $24.76M | $25.66M | $23.88M | $24.64M | $27.08M | $26.40M | $30.19M | $29.23M |
| **Total Debt (incl. Leases)** | $10.29M | $11.01M | $11.28M | $11.57M | $11.99M | $11.92M | $12.01M | $12.67M |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K |
| Retained Earnings | -$320.2M | -$309.6M | -$304.1M | -$293.0M | -$278.4M | -$257.3M | -$237.7M | -$217.1M |
| **Total Stockholders' Equity** | $57.07M | $66.40M | $74.21M | $84.47M | $102.4M | $115.5M | $130.0M | $159.3M |
| Total Equity | $57.13M | $66.48M | $74.29M | $84.56M | $102.5M | $115.6M | $130.1M | $159.5M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$66.46M | -$61.18M | -$73.45M | $5.32M | -$51.11M | -$17.93M |
| Depreciation & Amortization | $5.84M | $5.80M | $5.43M | $4.32M | $602K | $208K |
| Stock-Based Compensation | $468K | $4.71M | $5.05M | $9.88M | $16.49M | $3.62M |
| Change in Receivables | -- | $0 | $5.80M | -$5.83M | $559K | $479K |
| Change in Payables | -$2.20M | $898K | -$3.38M | $1.14M | -$3.53M | $586K |
| **Operating Cash Flow** | -$47.98M | -$28.94M | -$50.92M | -$14.43M | -$32.58M | -$11.03M |
| Capital Expenditure | -$37K | -$892K | -$5.41M | -$6.14M | -$1.15M | -$293K |
| **Free Cash Flow** | -$48.02M | -$29.83M | -$56.34M | -$20.57M | -$33.73M | -$11.32M |
| Acquisitions, Net | -- | -- | -- | -- | -$11.77M | -- |
| **Investing Cash Flow** | $416K | -$892K | -$5.41M | -$5.75M | -$12.91M | -$293K |
| Common Stock Issued | $0 | $2.16M | $2.04M | $484K | $102.8M | -- |
| **Financing Cash Flow** | $2.0K | $2.16M | $1.87M | $325K | $222.7M | $41.44M |
| **Net Change in Cash** | -$40.55M | -$29.69M | -$52.30M | -$19.67M | $170.8M | $31.83M |

### Cash Flow Statement (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$10.60M | -$5.53M | -$11.10M | -$14.57M | -$21.13M | -$19.66M | -$20.59M | -$8.13M |
| Depreciation & Amortization | $820K | $856K | $909K | $901K | $2.00M | $2.03M | $1.43M | $1.48M |
| Stock-Based Compensation | $433K | $556K | $696K | -$415K | -$281K | $468K | $755K | $1.14M |
| Change in Payables | -$451K | $644K | -$348K | -$1.04M | $342K | -$1.16M | -$460K | $391K |
| **Operating Cash Flow** | -$8.09M | -$3.37M | -$4.24M | -$10.73M | -$18.11M | -$14.90M | $13.09M | -$18.20M |
| Capital Expenditure | $0 | $0 | $0 | $0 | -$32K | -$5.0K | -$278K | -$114K |
| **Free Cash Flow** | -$8.09M | -$3.37M | -$4.24M | -$10.73M | -$18.14M | -$14.91M | $12.81M | -$18.31M |
| **Investing Cash Flow** | $61K | $55K | $2.0K | $451K | -$32K | -$5.0K | -$278K | -$114K |
| Common Stock Issued | -- | -- | $0 | $0 | $0 | $0 | $837K | $465K |
| **Financing Cash Flow** | $0 | $0 | $0 | $0 | $0 | $2.0K | $837K | $465K |
| **Net Change in Cash** | -$7.56M | -$4.66M | -$3.82M | -$12.11M | -$12.79M | -$11.82M | $6.30M | -$11.67M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -454.1% | -10463.1% | -9.0% | -16873.5% | -415.8% |
| **Net Profit Margin** | -- | -408.0% | -9145.5% | 11.9% | -18979.5% | -367.3% |
| Return on Equity (ROE) | -89.5% | -47.0% | -39.3% | 2.2% | -20.2% | -- |
| Return on Assets (ROA) | -67.7% | -38.1% | -34.2% | 2.0% | -18.1% | -34.9% |
| Current Ratio | 7.77x | 8.03x | 12.45x | 17.40x | 20.32x | 6.27x |
| Quick Ratio | 7.03x | 7.07x | 11.28x | 15.90x | 19.19x | 5.73x |
| Debt to Equity | 0.15x | 0.09x | 0.07x | 0.04x | 0.03x | -- |
| **Revenue Growth (YoY)** | -100.0% | +1766.5% | -98.2% | +16580.2% | -94.4% | -- |
| **Net Income Growth (YoY)** | -- | -- | -1473.0% | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -1464.3% | -- | -- | -- |
| 5Y Revenue / Share Growth | -100.0% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -- | -- | -- | -454.1% | -431.3% |
| **Net Profit Margin** | -- | -- | -- | -- | -- | -- | -408.0% | -386.3% |
| Return on Equity (ROE) | -73.2% | -78.8% | -89.5% | -89.8% | -67.8% | -56.5% | -47.0% | -36.3% |
| Return on Assets (ROA) | -51.0% | -56.8% | -67.7% | -69.5% | -53.6% | -45.9% | -38.1% | -30.6% |
| Current Ratio | 5.54x | 6.05x | 7.77x | 8.04x | 7.89x | 9.18x | 8.03x | 8.93x |
| Quick Ratio | 5.19x | 5.49x | 7.03x | 6.88x | 6.78x | 8.28x | 7.07x | -- |
| Debt to Equity | 0.18x | 0.17x | 0.15x | 0.14x | 0.12x | 0.10x | 0.09x | 0.08x |
| **Revenue Growth (YoY)** | -- | -- | -- | -100.0% | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -132.4% | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -133.1% | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
